MedPath

Lisdexamfetamine Dimesylate

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for .  Initial U.S. Approval: 2007

Approved
Approval ID

efbde0f6-b848-4664-b741-c6c630e66108

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 12, 2022

Manufacturers
FDA

Mylan Pharmaceuticals Inc.

DUNS: 059295980

Products 7

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6856
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (14)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 30 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6857
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (14)

LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 40 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6854
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (16)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 10 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0L
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6858
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (13)

LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 50 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6855
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (13)

FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 20 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6859
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (13)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 60 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT

lisdexamfetamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0378-6860
Application NumberANDA202835
Product Classification
M
Marketing Category
C73584
G
Generic Name
lisdexamfetamine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2022
FDA Product Classification

INGREDIENTS (15)

SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
LISDEXAMFETAMINE DIMESYLATEActive
Quantity: 70 mg in 1 1
Code: SJT761GEGS
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lisdexamfetamine Dimesylate - FDA Drug Approval Details